Fluent Perla CBD Suppository
Relief Can Be a Precious Thing – Perla is an Indica-dominant hybrid produced through a cross of Cannabis sativa and Cannabis indica plants and has a ratio of 1:40 THC:CBD. As our first in-house developed strain, Perla has demonstrated a consistently robust cannabinoid profile through numerous laboratory analyses, exhibiting record-breaking quantities of CBD above 29%. The terpene content is rich with an abundance of Linalool and Pinene, providing well-balanced effects in both the body and mind. Perla is a whole-plant product that contains concentrations of CBD, THC (<.8%), and a full range of other natural components found in cannabis including terpenes, flavonoids and other cannabinoids that contribute to the medicinal properties of cannabis.
Current medical literature supports the use of CBD rich products for the treatment of pediatric and drug-resistant epilepsy (in combination with other antiepileptic medications) and chronic neuropathic pain.
CBD Content: Approximately 97.6%
THC Content: Approximately <.8%
THC to CBD Ratio: 40:1
Dosing Units: 30 mg per capsule
Total Doses: 10 capsules per bottle
Sold By: Fluent
Leave Your Review: Write A Review
Request Online Ordering from Fluent on FLD
Out of stock
Ideal for localized pain, cramps and inflammation with prolonged effects. The absorption rate is very high and like other suppositories, the application puts the medication closer to internal cellular walls so essential cannabinoids enter the bloodstream quickly.
Patients are recommended to initiate treatment on the evening of Day 1 with 1 application. Remove suppository from packaging and insert rectally or vaginally. After 1 – 2 hours, patients reassess symptoms. If symptoms have improved or subsided, no additional applications are needed and patients can apply as necessary.
Perla® is contraindicated in patients:
• with hypersensitivity to cannabinoids (e.g., THC or CBD) or to any of the inert ingredients in Perla®;
• with a significant history of cardiovascular disease;
• with an active or previous psychotic or active mood or anxiety disorder; and
• who are pregnant, planning to become pregnant, or are breastfeeding.